Seragon Pharmaceuticals Inc.

Blocking and depleting receptors in estrogen-dependent tumors

 
• By Deborah Erickson
  
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Archive

More from Scrip